Throughout the workshops established entrepreneurs shared their knowledge and experiences on the different development stages of biotech companies. Erik van den Berg (AM-Pharma) gave strategic and practical tips on how to secure funding. From experience Van den Berg said:
“Finding financing requires perseverance. The only thing you should know in advance is that it will take longer and it will be more difficult than you think it will.”
Rein Strijker (Vitalnext) showed how to address venture capitalists. In a parallel session Markwin Velders (Kite Pharma) enlightened ‘the perfect deal’, where he elaborated on the acquisition of T-Cell Factory by Kite Pharma. Finally, Edward Kliphuis (MS Ventures) explained the procedure of MS Corporate Ventures.
In the afternoon plenary programme the winner of the Biobusiness Masterclass was awarded.